BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 16816061)

  • 41. Impact of pessary use on prolapse symptoms, quality of life, and body image.
    Patel M; Mellen C; O'Sullivan DM; LaSala CA
    Am J Obstet Gynecol; 2010 May; 202(5):499.e1-4. PubMed ID: 20171608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaginal surgery for pelvic organ prolapse using mesh and a vaginal support device.
    Carey M; Slack M; Higgs P; Wynn-Williams M; Cornish A
    BJOG; 2008 Feb; 115(3):391-7. PubMed ID: 18190377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term vaginal ring pessary use: discontinuation rates and adverse events.
    Sarma S; Ying T; Moore KH
    BJOG; 2009 Dec; 116(13):1715-21. PubMed ID: 19906018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient Satisfaction and Symptoms Improvement in Women Using a Vginal Pessary for The Treatment of Pelvic Organ Prolapse.
    Radnia N; Hajhashemi M; Eftekhar T; Deldar M; Mohajeri T; Sohbati S; Ghanbari Z
    J Med Life; 2019; 12(3):271-275. PubMed ID: 31666830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Symptoms and pelvic support defects in specific compartments.
    Miedel A; Tegerstedt G; Maehle-Schmidt M; Nyrén O; Hammarström M
    Obstet Gynecol; 2008 Oct; 112(4):851-8. PubMed ID: 18827128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pelvic organ prolapse.
    Weber AM; Richter HE
    Obstet Gynecol; 2005 Sep; 106(3):615-34. PubMed ID: 16135597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depressive symptoms affect outcomes of pessary use in postmenopausal women with uterine prolapse.
    Ai FF; Zhu L; Mao M; Zhang Y; Kang J
    Climacteric; 2018 Apr; 21(2):184-188. PubMed ID: 29397780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sexual function after surgery for stress urinary incontinence and/or pelvic organ prolapse: a multicenter prospective study.
    Rogers RG; Kammerer-Doak D; Darrow A; Murray K; Olsen A; Barber M; Qualls C
    Am J Obstet Gynecol; 2004 Jul; 191(1):206-10. PubMed ID: 15295367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pessary use and management for pelvic organ prolapse.
    Atnip SD
    Obstet Gynecol Clin North Am; 2009 Sep; 36(3):541-63. PubMed ID: 19932415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaginal pessaries and their use in pelvic relaxation.
    Sulak PJ; Kuehl TJ; Shull BL
    J Reprod Med; 1993 Dec; 38(12):919-23. PubMed ID: 8120847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical management of pelvic organ prolapse in women: a short version Cochrane review.
    Maher C; Baessler K; Glazener CM; Adams EJ; Hagen S
    Neurourol Urodyn; 2008; 27(1):3-12. PubMed ID: 18092333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relationship of vaginal prolapse severity to symptoms and quality of life.
    Digesu GA; Chaliha C; Salvatore S; Hutchings A; Khullar V
    BJOG; 2005 Jul; 112(7):971-6. PubMed ID: 15958002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse.
    Rogers RG; Kammerer-Doak D; Villarreal A; Coates K; Qualls C
    Am J Obstet Gynecol; 2001 Mar; 184(4):552-8. PubMed ID: 11262452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term quality-of-life outcome after mesh sacrocolpopexy for vaginal vault prolapse.
    Thomas AZ; Giri SK; Cox AM; Creagh T
    BJU Int; 2009 Dec; 104(11):1676-9. PubMed ID: 19522867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the incontinence dish pessary on urethral support and urodynamic parameters.
    Noblett KL; McKinney A; Lane FL
    Am J Obstet Gynecol; 2008 May; 198(5):592.e1-5. PubMed ID: 18455542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
    Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
    Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of genital prolapse on voiding.
    Romanzi LJ; Chaikin DC; Blaivas JG
    J Urol; 1999 Feb; 161(2):581-6. PubMed ID: 9915453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaginal reconstructive surgery for severe pelvic organ prolapses: a 'uterine-sparing' technique using polypropylene prostheses.
    De Vita D; Araco F; Gravante G; Sesti F; Piccione E
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):245-51. PubMed ID: 18321633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of overactive bladder after vaginal hysterectomy and associated repairs for pelvic organ prolapse.
    Diez-Itza I; Aizpitarte I; Becerro A; Sarasqueta C
    Gynecol Obstet Invest; 2009; 68(1):65-70. PubMed ID: 19407458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pessary evaluation for genital prolapse treatment: From acceptance to successful fitting.
    Vasconcelos CTM; Gomes MLS; Geoffrion R; Saboia DM; Bezerra KC; Vasconcelos Neto JA
    Neurourol Urodyn; 2020 Nov; 39(8):2344-2352. PubMed ID: 32846016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.